Blood tests for predicting Crohn's disease return
Part of Digestive system clinical trials.
This study looks at a person's blood to see if it can predict whether Crohn's disease will come back after bowel surgery. It may help doctors plan better follow-up care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You have Crohn's disease.
- You are planning to have surgery to remove part of your bowel (ileocolonic resection or re-resection).
- You have not taken antibiotics or probiotics in the 8 weeks before the blood and stool samples are collected.
- You agree to give extra blood and stool samples for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
This study follows adults with Crohn’s disease who need surgery to remove the ileocecal area. It aims to better understand post-operative outcomes and what to expect after the operation.
This study looks at what happens to people with Crohn's disease after they have surgery to remove a diseased part of their intestine. The goal is to find patterns or signs that might help predict whether the disease will come back, which could help doctors plan better follow-up care.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
Hear when a new Crohn's Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.